{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:38:45Z","timestamp":1793648325891,"version":"4.5.1"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"DOI":"10.13039\/501100020627","name":"Kerman Neuroscience Research Center, Kerman University of Medical Sciences","doi-asserted-by":"crossref","award":["97000899"],"award-info":[{"award-number":["97000899"]}],"id":[{"id":"10.13039\/501100020627","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Limited evidence is available to acknowledge the association between opium use and liver cancer. In a case\u2013control study, we recruited 117 cases of primary liver cancer (PLC) and 234 age and sex-matched neighborhood controls from 2016 to 2018. We calculated odds ratios (OR) for opium use and 95% confidence intervals (95% CI), using conditional logistic regressions. Compared with non-users the adjusted OR (AOR, 95% CI) for opium use was 6.5 (95% CI, 2.87\u201313.44). Compared with people who had no history of use, a strong dose\u2013response effect of opium use was observed by amount of use (AOR, 10.70; 95% CI, 3.92\u201328.70). Cumulative use of opium also indicated that using over 30 gr-year could increase the PLC risk dramatically (AOR, 11.0; 95% CI, 3.83\u201331.58). Those who used opium for more than 21 years were highly at risk of PLC (AOR, 11.66; 95% CI, 4.43\u201330.67). The observed associations were significant even among never tobacco smokers (including cigarette and water-pipe smoking).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>The results of this study indicate that opium use dramatically increased the risk of liver cancer. Because opioids are increasing for medical and non-medical use globally; accordingly, severe health consequences such as liver cancer have to be investigated widely.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-22-0158","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:44:20Z","timestamp":1663940660000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Opium Use and the Risk of Liver Cancer: A Case\u2013Control Study"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-2224","authenticated-orcid":false,"given":"Maryam","family":"Marzban","sequence":"first","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, Bushehr University of Medical Science, Bushehr, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-4067","authenticated-orcid":false,"given":"Elham","family":"Mohebbi","sequence":"additional","affiliation":[{"name":"2Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran, Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4628-4849","authenticated-orcid":false,"given":"AliAkbar","family":"Haghdoost","sequence":"additional","affiliation":[{"name":"3Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-6815","authenticated-orcid":false,"given":"Mohammad","family":"Aryaie","sequence":"additional","affiliation":[{"name":"4Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-6658","authenticated-orcid":false,"given":"Mohammad Javad","family":"Zahedi","sequence":"additional","affiliation":[{"name":"5Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-3664","authenticated-orcid":false,"given":"Zaher","family":"Khazaei","sequence":"additional","affiliation":[{"name":"6Nahavand School of Allied Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2718-4925","authenticated-orcid":false,"given":"Mohamad","family":"Gholizade","sequence":"additional","affiliation":[{"name":"7Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-7302","authenticated-orcid":false,"given":"Ahmad","family":"Naghibzadeh-Tahami","sequence":"additional","affiliation":[{"name":"8Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2025112418225468200_bib1","article-title":"Vienna: United Nations Office on Drugs and Crime, UNODC; 2019","author":"World drug report"},{"key":"2025112418225468200_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S1470-2045(20)30611-2","article-title":"Carcinogenicity of opium consumption","volume":"21","author":"WHO","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025112418225468200_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.28018","article-title":"Opium: an emerging risk factor for gastric adenocarcinoma","volume":"133","author":"Shakeri","year":"2013","journal-title":"Int J Cancer"},{"key":"2025112418225468200_bib4","first-page":"2","article-title":"Opium as a risk factor for upper gastrointestinal cancers: a population-based case\u2013control study in Iran","volume":"17","author":"Naghibzadeh Tahami","year":"2014","journal-title":"Arch Iran Med"},{"key":"2025112418225468200_bib5","doi-asserted-by":"crossref","first-page":"100768","DOI":"10.1016\/j.eclinm.2021.100768","article-title":"Opium as a carcinogen: a systematic review and meta-analysis","volume":"33","author":"Bidary","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2025112418225468200_bib6","doi-asserted-by":"crossref","first-page":"100772","DOI":"10.1016\/j.cegh.2021.100772","article-title":"Association between opium use and bladder cancer: a case\u2013control study in a high-risk area of Iran","author":"Rashidian","year":"2021","journal-title":"Clin Epidemiol Global Health"},{"key":"2025112418225468200_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ijc.33289","article-title":"Opium use and the risk of head and neck squamous cell carcinoma","volume":"148","author":"Mohebbi","year":"2021","journal-title":"Int J Cancer"},{"key":"2025112418225468200_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07296-0","article-title":"Is opium use associated with an increased risk of lung cancer? A case\u2013control study","volume":"20","author":"Naghibzadeh-Tahami","year":"2020","journal-title":"BMC Cancer"},{"key":"2025112418225468200_bib9","first-page":"567","article-title":"Opium as a risk factor for bladder cancer: a population-based case\u2013control study in Iran","volume":"18","author":"Akbari","year":"2015","journal-title":"Arch Iran Med"},{"key":"2025112418225468200_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/dyac031","article-title":"Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran","volume":"51","author":"Hadji","year":"2022","journal-title":"Int J Epidemiol"},{"key":"2025112418225468200_bib11","doi-asserted-by":"crossref","first-page":"e8227","DOI":"10.5812\/ijcm.8227","article-title":"Opium use and risk of lower gastrointestinal cancers: population-based case\u2013control study in South of Iran","volume":"10","author":"lankarani","year":"2017","journal-title":"Int J Cancer Manag"},{"key":"2025112418225468200_bib12","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.canep.2021.102017","article-title":"Opium use as an independent risk factor for pancreatic cancer: A case-control study","volume":"75","author":"Naghibzadeh-Tahami","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"2025112418225468200_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.34172\/aim.2021.27","article-title":"The Iranian study of opium and cancer (IROPICAN): rationale, design, and initial findings","volume":"24","author":"Hadji","year":"2021","journal-title":"Arch Iran Med"},{"key":"2025112418225468200_bib14","article-title":"Opium use and risk of lung cancer: a multicenter case-control study in Iran","author":"Rashidian","year":"2022","journal-title":"Int J Cancer"},{"key":"2025112418225468200_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3892\/ijo.2013.2046","article-title":"Upregulation of the \u03b4 opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo","volume":"43","author":"Tang","year":"2013","journal-title":"Int J Oncol"},{"key":"2025112418225468200_bib16","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/cncr.32789","article-title":"Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990\u20132017","volume":"126","author":"Liu","year":"2020","journal-title":"Cancer"},{"key":"2025112418225468200_bib17","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int J Cancer"},{"key":"2025112418225468200_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet North Am Ed"},{"key":"2025112418225468200_bib19","first-page":"306","article-title":"Incidence and trend of liver cancer in Iran","volume":"26","author":"Mirzaei","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"2025112418225468200_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugpo.2016.01.013","article-title":"National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran","volume":"31","author":"Nikfarjam","year":"2016","journal-title":"Int J Drug Policy"},{"key":"2025112418225468200_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.33574","article-title":"Cancer in Iran 2008 to 2025: recent incidence trends and short-term predictions of the future burden","author":"Roshandel","year":"2021","journal-title":"Int J Cancer"},{"key":"2025112418225468200_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025112418225468200_bib23","first-page":"1","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"Smoke","year":"2004","journal-title":"IARC, Lyon."},{"key":"2025112418225468200_bib24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"2025112418225468200_bib25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/add.13453","article-title":"Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey","volume":"111","author":"Amin-Esmaeili","year":"2016","journal-title":"Addiction"},{"key":"2025112418225468200_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/10826080701772348","article-title":"Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran","volume":"43","author":"Nakhaee","year":"2008","journal-title":"Subst Use Misuse"},{"key":"2025112418225468200_bib27","first-page":"65","article-title":"Measuring the \u2018world drug problem\u2019: 2019 and beyond. Collapse of the Global Order on Drugs: From UNGASS 2016 to Review 2019","author":"Bewley-Taylor","year":"2018"},{"key":"2025112418225468200_bib28","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1016\/S2214-109X(20)30059-0","article-title":"Opium use and subsequent incidence of cancer: results from the golestan cohort study","volume":"8","author":"Sheikh","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025112418225468200_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/2008-7802.157470","article-title":"Effects of opium consumption on coronary artery disease risk factors and oral health: results of kerman coronary artery disease risk factors study a population-based survey on 5,900 subjects aged 15\u201375 years","volume":"6","author":"Najafipour","year":"2015","journal-title":"Int J Prev Med"},{"key":"2025112418225468200_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3923\/jas.2005.380.382","article-title":"The household survey of drug abuse in Kerman, Iran","volume":"5","author":"Ziaaddini","year":"2005","journal-title":"J Appl Sci"},{"key":"2025112418225468200_bib31","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1055-9965.1068.13.6","article-title":"Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran","volume":"13","author":"Abnet","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025112418225468200_bib32","first-page":"541","article-title":"An exploratory study of units of reporting opium usein iran: implications for epidemiologic studies","volume":"22","author":"Mohebbi","year":"2019","journal-title":"Arch Iran Med"},{"key":"2025112418225468200_bib33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"2025112418225468200_bib34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1753-6405.2011.00682.x","article-title":"Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population","volume":"35","author":"Randall","year":"2011","journal-title":"Aust N Z J Public Health"},{"key":"2025112418225468200_bib35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41588-021-00928-6","article-title":"Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence","volume":"53","author":"Moody","year":"2021","journal-title":"Nat Genet"},{"key":"2025112418225468200_bib36","first-page":"3267","article-title":"Seroepidemiological study of hepatitis B, C, and HIV among blood donors in Kerman. Asian Pacific journal of cancer prevention","volume":"18","author":"Mohsenizadeh","year":"2017","journal-title":"APJCP"},{"key":"2025112418225468200_bib37","first-page":"270","article-title":"Incidence of hepatocellular carcinoma in Southeast Iran","volume":"10","author":"Moghaddam","year":"2010","journal-title":"Hepat Mon"},{"key":"2025112418225468200_bib38","doi-asserted-by":"crossref","first-page":"e32711","DOI":"10.1371\/journal.pone.0032711","article-title":"Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case\u2013control studies","volume":"7","author":"Shakeri","year":"2012","journal-title":"PLoS ONE"},{"key":"2025112418225468200_bib39","first-page":"60","article-title":"Opium use reporting error in case\u2013control studies: neighborhood controls versus hospital visitor controls","volume":"35","author":"Mohebbi","year":"2021","journal-title":"Med J Islam Repub Iran"},{"key":"2025112418225468200_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.puhe.2008.01.014","article-title":"Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis","volume":"122","author":"Xia","year":"2008","journal-title":"Public Health"},{"key":"2025112418225468200_bib41","first-page":"189","article-title":"Epidemiology of Hepatitis B in Iran from 2000 to 2016: a systematic review and meta-regression analysis","volume":"23","author":"Rezaei","year":"2020","journal-title":"Arch Iran Med"},{"key":"2025112418225468200_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/sirius-2018-0016","article-title":"United nations office on drugs and crime: world drug report 2017. 2017","volume":"2","author":"Merz","year":"2018","journal-title":"SIRIUS-Zeitschrift f\u00fcr Strategische Analysen"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0158\/3209150\/capr-22-0158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-22-0158\/3225160\/capr-22-0158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/1\/29\/3235306\/29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/16\/1\/29\/3235306\/29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:23:36Z","timestamp":1764026616000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/16\/1\/29\/712017\/Opium-Use-and-the-Risk-of-Liver-Cancer-A-Case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2023,1,4]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-22-0158","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22533412","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547072","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547072.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533412.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.30701837","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}